Qiagen N.V. (QGEN)
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Last price
- $50.33
- As of
Kresmion compiles this page from QGEN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
QIAGEN N.V. (QGEN): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-06.
See the full QGEN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for QGEN on one page. Preview it with sample data, then open it live with a free account.
Preview the QGEN dossierActive events for QGEN
- mediumTrend spike
QIAGEN N.V. search volume spiked +100 pts, unusual interest
- high13F: funds reduced
3 tracked funds reduced QGEN this 2026Q2, institutional consensus
- high13F: funds added
5 tracked funds increased QGEN this 2026Q2, institutional consensus
- high13F: funds added
3 tracked funds increased QGEN this 2026Q2, institutional consensus
- medium13F: new position
CITADEL ADVISORS LLC new position in QGEN
FREE, NO ACCOUNT
Every event on QGEN, as it fires
You are seeing 5 of 16 events recorded on QGEN since 2026-07-24.
The five above landed across 3 days. The other 11 were recorded on 1 other days. 11 of the 16 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
QGEN positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC FundCUSIP N72482156 · 2026Q2 | $150.4M | 0.10% |
| Point72 Asset Management, L.P. FundCUSIP N72482156 · 2026Q2 | $62.1M | 0.09% |
| CITADEL ADVISORS LLC FundCUSIP N72482156 · 2026Q2 | $32.5M | 0.02% |
| D. E. Shaw & Co., Inc. FundCUSIP N72482156 · 2026Q2 | $2.9M | 0.00% |
| TWO SIGMA INVESTMENTS, LP FundCUSIP N72482156 · 2026Q2 | $560K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, QGEN
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
More data on QGEN
QGEN against its peers
QGEN's operating margin of 22.3% ranks in the 97th percentile of 18 Diagnostics & Research sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.
| Metric | QGEN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.1B USD | 77.2M USD | 93 | 19 |
| Revenue YoY | 5.7% | n/a | n/a | 3 |
| Gross margin | 62.2% | 62.3% | 46 | 13 |
| Operating margin | 22.3% | -25.4% | 97 | 18 |
| Net margin | 20.3% | -20.6% | 88 | 19 |
| Return on equity | 11.2% | -8.7% | 79 | 16 |
Peers (21): TWST, ICLR, BLLN, CDNA, NEO, PSNL, OPK, BDSX, BNR, FONR.D, IMDX, QUCY, IDXG, MBAI, PRPO, LDDD, MDXH, AWHL, NDRA, XWEL, ADVB. Left out: PMDI (period gap), ANPCF (no annual filing), BIAF (no annual filing), NOTV.D (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (QGEN: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in QGEN on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on QGEN in the last 180 days.
Upstream: SEC EDGAR filings for QGEN
Kresmion, "QIAGEN N.V. (QGEN) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/QGEN. Upstream data: SEC EDGAR filings for QGEN.
Link to this data (HTML):
<a href="https://kresmion.com/research/QGEN">QIAGEN N.V. (QGEN) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow QGEN on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to QGEN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.